Format: Download Video of Slides with Synchronized Audio

Presenter: E.K. Schandl, PhD, MS

Cancer is usually detected by visualization. Clinical biochemical parameters, e.g. Cancer Profile (CA Profile) and Longevity Profile (expanded CA Profile), are capable to signal a developing malignancy much earlier. The methodologies used in this study are: Chemiluminescence (HCG, CEA, TSH, DHEA-S), IRMA (HCG) and enzyme kinetics (PHI, GGTP) HCG, the pregnancy/malignancy hormone is the autocrine proliferative factor. PHI is a neurokine, the autocrine motility factor. Telomerase is the immortality factor. According to this investigator, all three factors must be present for the development and sustenance of malignancies. Our data confirms the presence of PHI and HCG in most, if not all cancers. Reports indicate telomerase in biopsy cancer specimens, and it was not detected in normal tissues.